442. The Human Endogenous Retrovirus HERV-W Envelope Glycoprotein Forms Pseudotypes with HIV-1 Vectors

""  !?.%     -2?./    ->/  

   

 

   !?. >    !?.          #D.% 

     -'D./ >      C.   #D.    #   7 @          

      "       ,5=    .        

   8"; 3 89;    % C $=6J 2   

  

                   -(?/    - !)/     "    -" (?/  C,5B"

     

    #'(                      

    

                   >?!J    

   86        @ 7         

 $=6J   

   

 !?."   #D." -;9±;BH  B5±B8H >?!J  /       C." 

    -:5±,BH >?!J  /     

           !?.    -;,±;BH >?!J  / 

    C.    -66±88H >?!J  /     #D.    -B±8H >?!J  /       

 $=6J     !?.%2?.    >   

               #D.    - 6 3 89;    %/ $        -= 3 89;  8& 3 89;    %/ !?.             C.  -=9±8:H86±==H>??!J / 7 0      !?."

          C.   #D. 

        

 $=6J 2                      

               

442. The Human Endogenous Retrovirus HERV-W Envelope Glycoprotein Forms Pseudotypes with HIV-1 Vectors Dong Sung An,1 Yiming Xie,1 Si-Hua Mao,1 Paul Krogstad,2 Irvin S. Y. Chen.1 1 AIDS Institute, Department of Hematology and Oncology. Department of Microbiology, Immunology, Molecular Genetics & Medicine, University of California, Los Angeles, Los Angeles, California, United States; 2Department of Pediatrics and Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, California, United States.              -C>@./  1     :H                        $       C>@.  

   1     

 C                          

  

    

    

         '       

      

C>@."0              

          3 

     -2  < D   <    .  ;6 ==,8" ==,5/ -# (  *  ,999I69=7;:&";:5/         

                                                     0      

C>@."0                 C."8                                                    3  896 4%  ,5=       C>@."0             

              

  

                   0  

   G        C>@.   )     

     C."8                      

    C>@. 0           1                     C>@.       

               

                   C."8                              

S144

443. Long-T erm Postnatal Beta-Galactodsidase Long-Term Expression in T ransduced Hepatocytes of ImmunoTransduced Competent Mice after In-Utero Delivery of an EAIV Derived Lentiviral V ector V ia the Yolk Sac V essels Vector Via Vessels Michael Themis,1 Simon Waddington,1 Megha Nivsarkar,1 Susan Buckley,1 Lauraine Lawrence,1 Terry Cook,2 Faisal Allaf,1 Charles Coutelle.1 1 Cell and Molecular Biology, Imperial College, London, United Kingdom; 2Department of Histopathology, Imperial College, London, United Kingdom.      

               

                                         "                      3              

  #?"8      E            "      8B    -     ,8 / '  

     -8389:"83895% /      #D. 

       

 

            D @   β" 

        >1          ->'./   

     .(."       #.   β"       

      

 ;,   ; ,:   ;5

  E    3

           3        

    F"    β"     #  E 

   #D.      

     

         >'.   E 

    

 3   β"   G  3        ;,    ;5   E                   3          

   

 

 3   

                                           "      3       

                   

444. Pseudotyping Lentiviral V ectors with Envelope Vectors Glycoproteins Derived from Ross River Virus and Semliki Forest Virus Christoph A. Kahl,1 David A. Sanders,2 Kenneth Cornetta.3 1 Program in Medical and Molecular Genetics, Indiana University, Indianapolis, Indiana, United States; 2Department of Biological Sciences, Purdue University, West Lafayette, Indiana, United States; 3Division of Hematology/Oncology, Departments of Medicine, Medical and Molecular Genetics, and Microbiology/ Immunology, Indiana University, Indianapolis, Indiana, United States. 0                        

 .   ( .     -.(."/              '              

       3         @           -(      <    .  ,998 ;&-B/ ,B&=",B&5/                   

   

       @ @  .  -@@./      

                                 @@.        (  ?  .  -(?./   

 G

                         ,5=       "   

          @@. (?.   .(."          C.           

 ?   !   -?!/       3    C.                 

 6:          

   1    ,5=         ?!"

   

  ?    ;,        D

          

          -8&8±86;/389B-8B;±9,=/389& -,,=±8::/3 896 4%     .(." @@.   (?."  

          ?        @*'    1

@ "!@ -85=±9:&/8989@*'  % .(."-,&B±9&,/ 8989@*'  % @@. -698±,,=/895@*'  %   (?."  

              Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy